Pharmacy and Poisons Board

Pharmacy and Poisons Board

Ensuring Safety, Quality and Efficacy of Medicines

Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 38, showing 5 Applications out of 190 total, starting on record 41, ending on 45

# Protocol No Study Title Investigator(s) & Site(s) Application Status

41.

ECCT/17/07/01   ABCD
    Antibiotics for Children with Severe Diarrhea Trial   
Principal Investigator(s)
1. Judd Walson
Site(s) in Kenya
1. Rongo Sub-County Hospital (Migori county)
2. Ndhiwa Sub-County Hospital (Homa Bay county)
3. Rachuonyo Sub-County Hospital (Homa Bay county)
4. Isebania Sub-County Hospital (Migori county)
5. Awendo Sub-County Hospital (Migori county)
6. Mbita Sub-County Hospital (Homa Bay county)
 
Trial Status not yet recruiting
Protocol Date 27-06-2017
View

42.

ECCT/16/08/01   A5349/TBTC S31
    A5349/TBTC S31 “Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial”   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
Trial Status recruiting
Protocol Date 14-05-2015
View

43.

ECCT/16/07/03   CYP STUDY
    Primaquine metabolism and its association with CYP2D6 and CYP2C19 genotypes among adults living within Seme and Kisumu West sub-counties of Kisumu County, Western Kenya       
Principal Investigator(s)
1. BEN ANDAGALU
2. BEN ANDAGALU
Site(s) in Kenya
KOMBEWA CLINICAL RESEARCH CENTRE
 
Trial Status stopped
Protocol Date 12-07-2015
View

44.

ECCT/16/07/02   A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events
    A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events   
Principal Investigator(s)
1. Mark Loeb
Site(s) in Kenya
The Aga Khan University Hospital
 
Trial Status In follow-up
Protocol Date 08-07-2015
View

45.

ECCT/16/07/01   VAC52150EBL4001
    A Multi-country, prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines AD26.ZEBOV and or/ MVA-BN-Filo   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Kenya medical Research Institute/Walter Reed Project Kombewa (Kisumu county)
3. Kenya medical Research Institute/Walter Reed Project Kombewa (Kericho county)
 
Trial Status In follow-up
Protocol Date 25-11-2015
View